Previous studies have shown that high levels of ATP6V1G1 are associated with short overall survival in glioblastoma (GBM) and ATP6V1G1 interacts with other factors to reprogram the surrounding non-tumor microenvironment to a pro-tumor state [14]. This evidence concerns the gene ATP6V1G1 and glioblastoma.